Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters

The development of novel optimized vaccines against coronavirus disease 2019 (COVID-19) that are capable of controlling the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic and the appearance of different variants of concern (VoC) is needed to fully prevent the transmission of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdelnabi, Rana, Pérez, Patricia, Astorgano, David, Albericio, Guillermo, Kerstens, Winnie, Thibaut, Hendrik Jan, Coelmont, Lotte, Weynand, Birgit, Labiod, Nuria, Delgado, Rafael, Montenegro, Dolores, Puentes, Eugenia, Rodríguez, Esteban, Neyts, Johan, Dallmeier, Kai, Esteban, Mariano, García-Arriaza, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619667/
https://www.ncbi.nlm.nih.gov/pubmed/37920464
http://dx.doi.org/10.3389/fimmu.2023.1163159

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619667/
https://www.ncbi.nlm.nih.gov/pubmed/37920464
http://dx.doi.org/10.3389/fimmu.2023.1163159

Ejemplares similares